Sirolimus-AssociatedPneumonitis in Heart Transplant Recipients

Ficha técnica o resumen de las características del producto. www.emea.europa.eu/humandocs/PDFs/EPAR/rapamune/H-273-PI-es.pdf (accessed 2008 Jun 9).

Rapamune (sirolimus) oral solution and tablets, www.fda.gov/cder/foi/label/2003/021083s0061bl.pdf (accessed 2008 Jun 9).

Delgado J , Torres J , Ruiz-Cano MJ . Sirolimus-associated interstitial pneumonitis in 3 heart transplant recipients. J Heart Lung Transplant 2006;25:1171–4.

Lindenfeld J , Simon S , Zamora M. BOOP is common in cardiac transplant recipients switched from a calcineurin inhibitor to sirolimus. Am J Transplant 2005;5:1392–6.

Morelon E , Stern M , Israël-Biet D. Characteristic of sirolimus-associated interstitial pneumonitis in renal transplant patients. Transplantation 2001;72:787–90.

Naranjo CA , Busto U , Sellers EM . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–45.

Champion L , Stern M , Israel-Biet D. Sirolimus-associated pneumonitis: 24 cases in renal transplant recipients. Ann Intern Med 2006;144:505–9.